CEO of Stem Cell Product Manufacturing Firm Pleads Guilty to Felony Distribution of Unapproved Drug

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

CEO of Stem Cell Product Manufacturing Firm Pleads Guilty to Felony Distribution of Unapproved Drug

Dennis Tosh

August 28, 2024 at 06:12 PM EST

The founder and CEO of a firm that marketed stem cell-based products linked to multiple hospitalizations pleaded guilty Aug. 26 to one felony count of introducing an unapproved drug into interstate commerce with the intent to defraud and mislead (United States v. Kosolcharoen, No. 8:24-cr-00088-ODW (C.D. Cal.)). A criminal information filed July 19 in the U.S. District Court ... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

CEO of Stem Cell Product Manufacturing Firm Pleads Guilty to Felony Distribution of Unapproved Drug

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT